Amy Antoniolli was quoted on how fund management firms, banks, and broker-dealers can approach their vendors regarding their environmental, social, and governance (ESG) policies.
Arent Fox Firmwide Managing Partner Cristina A. Carvalho has once again been selected by Washingtonian magazine as one of the "Most Powerful Women in Washington."
Schiff Hardin attorneys Joel Wallace and Helen Ji have been recognized as 2021 Rising Starts by Managing Intellectual Property. This is Helen’s second year of recognition and Joel’s first year.
Partner Imron Aly was quoted regarding a letter from the U.S. Food and Drug Administration (FDA) sent to the U.S. Patent and Trademark Office (USPTO) with suggestions on how to prevent some patent-owning pharmaceutical companies from blocking generics from entering the market.
On Sept. 9, President Joe Biden announced that the U.S. Department of Labor is developing an emergency rule to require all employers with 100 or more employees to ensure their workforces are fully vaccinated or show a negative test at least once a week.
Senior Government Relations Advisor Phil English, a former seven-term member of Congress from Pennsylvania, testified before the State Government Committee of the Pennsylvania House on the issue of Congressional reapportionment.
Partner Mir Ali discussed his path to partnership in’s inaugural “How I Made Partner” series. Mir said that he was fortunate to have been well informed of the expectations and responsibilities of becoming partner.
Intellectual Property Practice Group Co-Leader Imron Aly was quoted on the recent U.S. Supreme Court ruling in Minerva v. Hologic. The decision modified and limited the previous bar on inventors from challenging the validity of their patents after they have been assigned to others.
Intellectual Property Practice Group Co-Leader Imron Aly was quoted on the U.S. Supreme Court ruling in United States v. Arthrex.
Intellectual Property Group Co-Leader Imron Aly was featured among intellectual property and patent litigation thought leaders on the U.S. Supreme Court’s decision in United States v. Arthrex, Inc.